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Abstract
Background: Although lobectomy is considered the standard surgery for any
non-small cell lung cancer (NSCLC), recent evidence indicates that for early
NSCLCs segmentectomy may be equally effective. For segmentectomy to be
oncologically safe, however, adequate intraoperative lymph node staging is essen-
tial. The aim of this study was to compare the results of a new rapid-IHC system
to the HE analysis for intraoperative nodal diagnosis in lung cancer patients con-
sidered for segmentectomy.
Methods: This retrospective study analyzed the pathological reports from
NSCLC resections over a six-year period between 2014 and 2020. Using a new
device for rapid-IHC, we applied a high-voltage, low-frequency alternating cur-
rent (AC) field, which mixes the antipancytokeratin antibody as the voltage is
switched on/off. Rapid-IHC can provide a nodal diagnosis within 20 minutes.
Results: Frozen sections from 106 resected lymph nodes from 70 patients were
intraoperatively evaluated for metastasis. Of those, five nodes were deemed posi-
tive based on both HE staining and rapid-IHC. In addition, rapid-IHC alone
detected isolated tumor cells in one hilar lymph node. Three cStage IA patients
with nodal metastasis detected with HE staining and rapid-IHC received com-
plete lobectomies. Five-year relapse-free survival and overall survival among
patients receiving segmentectomy with rapid-IHC were 88.77% and 88.79%,
respectively.
Conclusions: Rapid-IHC driven by AC mixing is simple, highly accurate, and
preserves nodal tissue for subsequent tests. This system can be used effectively
for intraoperative nodal diagnosis.
Rapid immunohistochemistry based on alternating-current field mixing (com-
pleted within 20 minutes) is simple and highly accurate. This system will assist
clinicians when making intraoperative diagnoses of lymph node metastasis and
deciding upon the appropriate surgical procedure in segmentectomy for lung
cancer.
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Key points
Significant findings of the study
Rapid immunohistochemistry driven by alternating-current field mixing (com-
pleted within 20 minutes intraoperatively) is simple, highly accurate, and pre-
serves lymph node tissue for subsequent pathological examination, including
molecular assessments.
What this study adds:
Segmentectomy for lung cancer is oncologically safe, but only when there is ade-
quate intraoperative node staging. Rapid immunohistochemistry will assist clini-
cians when making intraoperative nodal diagnoses.
Introduction
Lung cancer is the most common cause of cancer-related
death globally. In cases of non-small cell lung cancer
(NSCLC), surgery remains the best option for a potential
cure. The Lung Cancer Study Group (LGSG) showed a pref-
erence for lobectomy over sublobar resection because it pro-
vides better local control, as demonstrated by a threefold
decrease in local recurrence and improved survival for
patients with pathological T1N0M0 NSCLC.1 Although
lobectomy and systematic lymph node dissection are the stan-
dard surgical procedures for any primary NSCLC, that is
based on results from a single randomized trial published in
1995.1 More recent evidence suggests that segmentectomy for
small, stage I lung cancer can yield outcomes that are equiva-
lent to lobectomy.2–4 To date, two multicenter, prospective,
randomized studies investigating the feasibility of sublobar re-
section for peripherally located clinical T1 lung cancer are
underway (Cancer and Leukemia Group B (CALGB/Alliance)
140 503; The Japan Clinical Oncology Group (JCOG) 0802/
West Japan Oncology Group (WJOG) 4607L).5–7
Although anatomic segmentectomy with hilar and
mediastinal lymph node dissection was performed in the
experimental treatment arm of the JCOG0802/WJOG4607L
phase III trial, the surgical procedure must be converted to a
lobectomy when regional lymph node metastasis is present
or the resection margin is not cancer-free.5, 7 This means
that intraoperative lymph node exploration is necessary to
avoid incomplete resection when treating with sublobar
resection, as N1 or N2 disease may be present; 13%–17.9%
of clinical stage I patients have been reported to have
mediastinal lymph node involvement.8–11 Segmentectomy
for early small NSCLCs is an oncologically safe and reason-
able alternative to lobectomy, but only when there is ade-
quate intraoperative lymph node staging, as surgeons cannot
complete segmental/subsegmental lymph node dissection for
the remaining lung segment.
Intraoperative frozen section diagnosis using hematoxy-
lin and eosin (HE) staining has traditionally been used to
assess indeterminate lung lesions and guide surgical man-
agement. As a successful radical segmentectomy must be
oncologically adequate, the accuracy of frozen
section diagnosis is more important than ever.12, 13 How-
ever, micrometastasis or isolated tumor cells (ITCs) within
lymph nodes sometimes cannot be detected on the basis of
HE staining alone. On the other hand, the sensitivity of
immunohistochemistry (IHC) using an epithelial marker
such as an anticytokeratin antibody is sufficient to detect
micrometastasis or ITCs. Unfortunately, the standard pro-
tocol requires two to four hours to complete. To overcome
that limitation, we have developed a rapid-IHC method
that makes use of an alternating current (AC) electric field
to facilitate the antigen-antibody reaction. With this device,
we have applied a high-voltage, low-frequency AC electric
field to the tissue sections.14–16 The antibody is mixed
within microdroplets as the voltage is switched on and off
at specific intervals. The resultant coulomb force stirs the
diluted solution on the sections, which increases the oppor-
tunity for contact between the antigen and antibody
(AC mixing). This rapid-IHC method enables prompt
detection of target cells within frozen sections and can pro-
vide a surgeon with an intraoperative diagnosis within
20 minutes, as opposed to the two to four hours required
for conventional IHC.14–18
The aim of the present study was to compare the results
of a new rapid-IHC system to the HE analysis for
intraoperative nodal diagnosis in clinical stage I NSCLC
patients considered for segmentectomy.
Methods
Patients
All experimental protocols were approved by the institu-
tional review board at Akita University Hospital (approval
number: 896, 929 & 2426 for the retrospective review), and
all samples were collected under this IRB Protocol
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No. 2426, which allows collection of tissue and medical
record with consent or waiver of consent when no person-
alized health information is required, as was the case for
this study. The medical records of 118 patients who under-
went (or planned to undergo) pulmonary segmentectomy
for clinical stage I NSCLC (UICC TNM Classification of
Malignant Tumors eighth edition)19 between January 2014
and February 2020 at our institute were retrospectively
reviewed. Segmentectomy was performed in patients
with clinical stage I or with computed tomography
(CT) findings of ground-glass shadows, which may indicate
an underlying minimally invasive adenocarcinoma. The
other eligibility criteria were as follows: number of radio-
logically suspicious lung cancer lesions ≤3; main tumor
located the outer third of the lung field on CT and no sign
of nodal involvement; and lobectomy feasible. In 70 of
these patients, intraoperative evaluation of lymph nodes
for metastasis was performed using rapid-IHC with frozen
sections. The patient characteristics are listed in Table 1.
Surgical procedure
All patients received standard pre- and intraoperative care.
Segmentectomy was defined as resection of one segment or
one segment and its adjacent segments. Because an ade-
quate margin of healthy lung tissue was required, the pul-
monary resection line could be placed on the segment
adjacent to the affected one or portions of a few adjacent
segments or subsegments extirpated. After completing the
resection, frozen section (FS) examination confirmed that
in all the analyzed patients the tumor was completely
removed and that the lymph nodes removed were negative
for involvement. If the resection was incomplete because of
an inadequate surgical margin and anatomical difficulty, or
intraoperative pathological analysis revealed the tumor to
be greater than N0, the patient was converted to lobec-
tomy. The frozen section slides for both HE staining and
rapid IHC were prepared from the same lymph node sam-
ple at the same time intraoperatively. Our pathologists
relied on intraoperative diagnosis of lymph node metastasis
based solely on HE staining, but retained the optional diag-
nosis with rapid-IHC. The rapid IHC was only a guide in
the present retrospective study.
Noncontact alternating-current electric-
field mixing
It is known that when an AC electric field is applied to a
solution, electro-osmotic vortices are produced that induce
noncontact mixing. We have been developing a rapid-IHC
method that makes use of an AC electric field to facilitate
the antigen-antibody reaction. The rapid-IHC device
mounts with a temperature control unit and is equipped
with a humidifier to prevent evaporation of the micro-
droplet. Microscope slides are placed between the elec-
trodes, and a high voltage (4.0–4.5 kVp-p, offset 2.25 kV),
Table 1 Characteristics of patients
Characteristic Characteristic
Patients, n 70
Age, years 68.3  8.8 Tumor location, n
Sex, n Right S1 4
Male 36 S2 9
Female 34 S3 6
S6 8
Tumor size (mm) Average 16.5 S7 1
Histology, n S8 5
Adeno 62 S9 3
Squamous 7 S10 0
Other histology 1 Left S1 + 2 15
p-stage S3 5
0 4 S4 6
IA1 22 S5 1
IA2 30 S6 3
IA3 3 S8 2
IB 6 S9 1
IIA 1 S10 0
IIB 1 S8/S9 1
IIIA 3 Node status, n
pN0/N1/N2 66/1/3
Diagnosed LNs, n 106
Adeno, adenocarcinoma; S, segment; Squamous, squamous cell carcinoma.
Thoracic Cancer 11 (2020) 3547–3554 © 2020 The Authors. Thoracic Cancer published by China Lung Oncology Group and John Wiley & Sons Australia, Ltd. 3549
K. Imai et al. Nodal diagnosis using rapid-IHC
low-high frequency (5–90 Hz) AC electric field is applied.
The device features an air insulation layer between the
upper-electrode and the microdroplet. Relative permittiv-
ities of the air insulation and microdroplet (when the drop-
let is pure water) are εa = 1 and εr = 80, respectively. An
attractive force mainly acts on the microdroplet and
induces a positive electric field direction due to the differ-
ence between the relative permittivities (εa < εr). Even
without a stirrer, the antibody is mixed within the micro-
droplet as the voltage is switched on and off in a time
series (I ! II ! III ! IV, Fig 1). The resultant coulomb
force stirs the reagent solution on the sections, and the
opportunity for contact between the antibody and antigen
is increased as the voltage is turned on and off at regular
intervals, transforming the shape of the microdroplet.
Rapid immunohistochemistry (IHC)
The same frozen sections of lymph node were used for
both HE staining and IHC intraoperatively. Resected
lymph nodes were cut at 2 mm intervals, then immediately
embedded in optimum cutting temperature compound,
frozen for 30 seconds in liquid acetone at −80C using
a frozen specimen block preparation system, and trans-
ferred to a cryostat for sectioning. Anti-pancytokeratin
(CK) antibody cocktail (AE1/AE3 approved as in vitro
Diagnostics; IR053, Dako) in a 150 μL volume was applied
to the sections under a high-voltage (4.0 kVp-p, offset 2.25
kV), low-frequency (5 Hz) AC electric field. Procedures
and times for IHC are summarized in Table S1.
Patient follow-up
Within two months after surgery, patients were evaluated
for follow-up based on a physical examination, chest x-ray,
CT, and laboratory tests. Although the follow-up schedule
after surgery varied, it usually entailed a chest CT every
three to six months and brain magnetic resonance imaging,
bone scintigraphy, and/or positron emission tomography/
CT every 6–12 months for the first two years. This was
followed by evaluations every 6–12 months. If recurrence
was suspected, the follow-up schedule was tightened. Post-
operative adjuvant chemotherapy was recommended if the
pathological findings revealed a tumor diameter of 2 cm or
greater, or if lymph node metastasis was present.
Statistical analysis
Group data are expressed as means  standard deviation.
Kaplan-Meier analysis was used to estimate five-year
relapse-free survival (RFS) and five-year overall survival
(OS). The log-rank test was used to assess the impact of
rapid-IHC on PFS and OS. P-values were two-sided and
considered significant if less than 0.05. Statistical analyses
were performed using JMP IN 14.2.0 software (SAS Insti-
tute, Cary, NC, USA).
Results
Between January 2014 and February 2020, 70 clinical stage
I NSCLC patients were deemed eligible for inclusion in this
study. A diagram of the selection process is shown in
Figure 1 Rapid immunohistochemistry that makes use of an alternating current electric field to facilitate the antigen-antibody reaction. (a) Histo-Teq
R-IHC. The device used to apply a high-voltage, low-frequency AC electric field can provide surgeons with an accurate intraoperative nodal diagnosis
within 20 min. (b) Schema of the changes in the microdroplet as the voltage is switched on and off. The antibodies are mixed within the micro-
droplet as the voltage is switched on and off in a time series (I ! II ! III ! IV). The resultant coulomb force stirs the antibody solution on the sec-
tions, and the microdroplet’s shape is transformed. This increases the opportunity for contact between the antibody and antigen.
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Figure 1, and the clinical characteristics of the patients are
summarized in Table 1. The median follow-up period was
3.70 years (range, 0.04 to 5.77 years). A total of 62 of these
patients underwent segmentectomy, while the remaining
eight patients were converted to lobectomy after
intraoperative diagnosis. The causes of the conversions are
summarized in Table 2.
Table 2 Summarized outcomes of eight patients who were converted lobectomy from segmentectomy after intraoperative diagnosis
No.
(Age/sex) Location Histology cStage pStage FS of LNs
R-IHC






Adeno IA2 IA2 #12u− #12u− Anatomical difficulty based
on PA
A 5.71




Positive LNs metastasis A 5.24








Hilar adhesion due to
lymphadenopathy by IPF
D‡ 1.23





69/F Rt. S1 Adeno IA1 IA2 #4−, #12u− #4−,
#12u−
Tumor position A 2.92
61/F Lt. S3 Adeno IA1 IIIA #10 +† #10 +† Positive LN metastasis A 0.30
62/F Lt. S8 Adeno IA1 IA2 #12l− #12l− Anatomic extent of VPI A 0.04
†8 mm micrometastasis. ‡Death by acute exacerbation of interstitial pneumonia. −, negative metastasis; +, positive metastasis; A, alive without recur-
rence; D, death; FS, frozen sections; IPF, idiopathic pulmonary fibrosis; LN, lymph node; PA, pulmonary artery; PA, pulmonary artery; R, recurrence;
VPI, visceral pleural invasion.
Table 3 Comparison of intraoperative frozen section (hematoxylin and
eosin stain) and final pathological diagnosis for detection of cancer cells
among clinically dissected lymph nodes
Final pathology, number of LNs
Positive Negative Total
FS (HE staining)
Positive 5 0 5
Negative 0 101 101
Total 5 101 106
FS, frozen section; LN, lymph node.
Table 4 Comparison of intraoperative rapid-immunohistochemistry
and final pathological diagnosis for detection of cancer cells among
clinically dissected lymph nodes
Final pathology, number of LNs
Positive Negative Total
Rapid-IHC
Positive 5 1† 6
Negative 0 100 100
Total 5 101 106
†In one case isolated tumor cells were detected by intraoperative rapid-
IHC alone.
Figure 2 Isolated tumor cells of intrathoracic lymph node by rapid
immunohistochemistry using noncontact alternating current electric
field mixing. Isolated tumor cells detected within a resected intratho-
racic lymph node with rapid immunohistochemistry (IHC) alone; these
cells were not detected by intraoperative HE staining. Shown are
images of positive staining for antipancytokeratin AE1/AE3 antibody
with rapid-IHC (a) and HE staining (b). The patient was diagnosed as
pN0 (i+).
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A total of 106 resected lymph nodes were examined
intraoperatively. Of those, 100 were judged to be negative
based on HE staining, and this was confirmed by the
rapid-IHC (Tables 3 and 4). On the other hand, five
(including three mediastinal/hilar nodes originated from
one patient) were deemed positive based on both conven-
tional HE staining and rapid-IHC. In addition, rapid-IHC
alone revealed the presence of ITCs in a hilar lymph node
from one patient who received radical segmentectomy with
systemic lymph node dissection (T2 [invades visceral
pleura] N0M0, pathological stage IB) (Fig 2). Two years
later, that patient had a recurrence with multiple metasta-
ses in mediastinal lymph nodes and pleural dissemination.
Three patients were intraoperatively diagnosed with posi-
tive lymph node metastasis based on both HE staining and
rapid-IHC and converted to lobectomy were still alive at
the end of follow-up (Table 2).
Five-year RFS and OS among all the clinical stage I
patients who completed radical segmentectomy and received
an optional diagnosis using rapid-IHC (n = 62) were 88.77%
(95% CI: 76.88–94.94) and 88.79% (95% CI: 75.46–95.33),
respectively (Fig 3). There was no significant difference
between complete and incomplete segmentectomy for RFS
or OS (log-rank P = 0.1542 and 0.6106, respectively). The
rate of distant metastasis and local recurrence, including
regional lymph node metastasis, in patients who completed
radical segmentectomy with rapid-IHC were 1.6% (1/61
patients, excluding one patient with ITCs) and 3.3% (2/60
patients, excluding one patient with ITCs and one patient
with bilateral lung cancer), respectively.
Discussion
In the present study, we demonstrated that rapid-IHC
using anti-CK antibodies (AE1/AE3) and AC mixing can
be used to intraoperatively diagnose intrathoracic lymph
node metastasis within 20 minutes during segmentectomy
for patients with NSCLC. The five-year OS after radical
segmentectomy was 88.79%, and segmentectomy with
intraoperative lymph node diagnosis with rapid-IHC
should be considered an effective and accurate method to
guide resection strategy for small peripheral NSCLCs.
Micrometastases or ITCs detected by IHC alone in
patients with HE-negative lymph node metastasis has been
reported to be controversial with survival.20,21 The prog-
nostic role of micrometastasis or ITCs within intrathoracic
lymph nodes in primary patients with lung cancer is also
controversial, and it is still unclear how their presence
should be used for pathological staging and treatment
planning. Two meta-analyses of 13 studies reported no sig-
nificant association between micrometastases and survival,
and that NSCLC patients probably should not be upstaged
due to the presence of ITCs and micrometastases.22,23 In
addition, these studies provided no data suggesting that
stage II/III NSCLC patients with pN(i+) or pN(mi) benefit
from adjuvant chemotherapy and/or radiation therapy.22
Thus, the significance of nodal micrometastases and ITCs
in lung cancer remains a topic of shifting opinion.
Molecular diagnosis of nodal metastasis has been attempted
for various types of cancer.24–31 In cases of NSCLC, nodal
involvement has been tested using qRT-PCR29,30 and one-step
nucleic acid amplification (OSNA),28 was developed as a quick
(30–40 minutes) and semiautomatic procedure for detection
of lymph node metastasis by targeting CK19 mRNA. How-
ever, because OSNA requires tissue homogenization, it is
limited by the frequency of false-positives caused by the inabil-
ity to make morphological observations. Moreover, allocation
bias is suspected to be the reason for the discrepancy between
OSNA and histopathological diagnoses, as these two methods
were applied to different lymph node slices in some clinical
studies.28, 31 That is also one of our limitations, although
rapid-IHC offers advantages over OSNA. First, rapid-IHC is a
simple procedure employing antigen-antibody reactions and
preserves the ability for morphological observation. Second,
Figure 3 Relapse-free survival (a) and overall survival (b) of clinical
stage I eligible patients receiving completed segmentectomy.
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the same frozen sections of lymph node can be both used for
both HE staining and IHC; consequently, with rapid-IHC it is
not necessary to replace conventional histopathological
diagnoses.
After standard surgery, the rate of recurrence among
patients with stage I NSCLC ranges from 6% to 10% per
person-year during the first four years, with 5% to 10% of
patients eventually developing local recurrence and 10%
to 20% developing distant metastasis within the first
four years.1, 32, 33 In the present study, the rates of distant
metastasis and local recurrence in patients receiving com-
plete radical segmentectomy and intraoperative diagnosis
with rapid-IHC were 1.6% and 3.3%, despite segmentectomy
being a fundamentally more limited parenchymal resection.
However, intraoperative diagnosis of lymph nodes metasta-
sis using rapid-IHC with anti-CK antibody could potentially
lead to false positive and overdiagnosis because the prognos-
tic impact of lymph node micrometastasis/ITCs in lung can-
cer is unclear, while having the possibility of better patient
outcomes. Further investigation will be needed to evaluate
the intraoperative rapid IHC for lymph node metastasis.
That said, rapid-IHC driven by AC mixing has several
limitations. First, because pores created when an electric
current is applied to the cell membrane could cause false
positives and over-diagnosis, and it is important to con-
sider the effect of electroporation when using the AC
mixing device for IHC. In our earlier report, we showed
that the electric current does not flow through the inside of
microdroplets during AC mixing.16 This is because the
stirred microdroplet is separated from the electrode by
both glass and air, which act as insulators. As a result, no
pores are created. Second, rapid-IHC is subject to human
error because the IHC steps are performed manually. To
address this limitation, we are developing a new one-step
fully automated rapid-IHC device, which reduces the effort
of researchers and technicians and stabilizes the quality of
any IHC stain. The important third limitation of this study
is its small sample size and possible selection and alloca-
tion bias, which are the main pitfalls of histological tissue
comparison studies. The analysis of survival data has pro-
vided interesting results, but these results should be inter-
preted cautiously. There were only a small number of
patients who required conversion to lobectomy. To com-
plete this new diagnostic system, future analysis of a larger
number of patients undergoing converted lobectomy will
be required.
In summary, our rapid-IHC system could potentially serve
as a novel and effective procedure for intraoperative diagno-
sis of lymph node metastasis during segmentectomy in
NSCLC patients. The advantages of this procedure are its
simplicity, high accuracy, cost-effectiveness, and preservation
of lymph node tissue for subsequent pathological examina-
tion including molecular assessments. Rapid-IHC will help
pathologists and surgeons when making intraoperative diag-
noses during radical lung cancer surgery.
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